AAPM Task Group 108: PET and PET/CT Shielding Requirements

Medical Physics

Volumn 33, Issue 1, 2006, Pages 4-15

  Madsen, Mark T ^a   Anderson, Jon A ^b   Halama, James R ^c   Kleck, Jeff ^d   Simpkin, Douglas J ^e   Votaw, John R ^f   Wendt III, Richard E ^g   Williams, Lawrence E ^h   Yester, Michael V ⁱ  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^d Attainia

^e St Luke's Medical Center   (United States)

^f EMORY UNIVERSITY   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h City of Hope Medical Center   (United States)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMERAS; COMPUTERIZED TOMOGRAPHY; COST EFFECTIVENESS; DIAGNOSIS; POSITRONS; RADIOISOTOPES; SHIELDING;

ANNIHILATION PHOTONS; COST EFFECTIVE DESIGN; EQUIPMENT VENDORS; MEDICAL PHYSICISTS; POSITRON EMISSION TOMOGRAPHY (PET); RADIATION SAFETY STANDARDS; RADIOACTIVE SOURCES; SCINTILLATION CAMERAS;

POSITRON EMISSION TOMOGRAPHY;

CARBON 11; COPPER 64; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; IODINE 124; NITROGEN 13; OXYGEN 15; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; RUBIDIUM 82; TRACER;

COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; ENERGY; GLUCOSE METABOLISM; HALF LIFE TIME; HEART MUSCLE PERFUSION; HUMAN; MATHEMATICAL ANALYSIS; MONTE CARLO METHOD; NUCLEAR MEDICINE; PATIENT POSITIONING; PHOTON; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PROTECTION; RADIATION SAFETY; RADIOACTIVITY; REVIEW; SCINTILLATION CAMERA;

EID: 31044441444     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2135911     Document Type: Review

References (33)

1. J. C. Courtney et al., "Photon shielding for a positron emission tomography suite," Health Phys. 81, S24-28 (2001).
2. M. P. Frick et al., "Considerations in setting up a positron emission tomography center," Semin Nucl. Med. 22, 182-188 (1992).
3. K. J. Kearfott et al., "Radiation protection design for a clinical positron emission tomography imaging suite," Health Phys. 63, 581-589 (1992).
4. B. M. Methe, "Shielding design for a PET imaging suite: a case study," Health Phys. 84, S83-88 (2003).
5. M. D. Harpen, "Positronium: Review of symmetry, conserved quantities and decay for the radiological physicist," Med. Phys. 31, 57-61 (2004).
6. P. Alagona, Jr., D. T. Hart, and E. A. Eikman, "Regional distribution of 2-deoxy-2[18F]-fluoro-D-glucose for metabolic imaging using positron emission tomography," Int. J. Card. Imaging 10, 137-143 (1994).
7. H. R. Schelbert et al., "PET myocardial perfusion and glucose metabolism imaging: Part 2-Guidelines for interpretation and reporting PET myocardial glucose metabolism and perfusion imaging: Part 1-Guidelines for data acquisition and patient preparation," J. Nucl. Cardiol. 10, 557-571 (2003).
8. ANS, ANSI/ANS-6.1.1-1991: Neutron and Gamma-Ray Fluence-To-Dose Factors (American Nuclear Society, LaGrange Park, IL, 1991).
9. ANS, ANSI/ANS-6.1.1-1977: Neutron and Gamma-Ray Fluence-To-Dose Factors (American Nuclear Society, LaGrange Park, IL, 1977).
10. B. R. Archer, J. I. Thornby, and S. C. Bushong, "Diagnostic X-ray shielding design based on an empirical model of photon attenuation," Health Phys. 44, 507-517 (1983).
11. NCRP, NCRP Report 49: Structural Shielding Design and Evaluation for Medical Use of X Rays and Gamma Rays of Energies up to 10 MeV (National Council on Radiation Protection, Bethesda, MD, 1976).
12. German Deutsches Institut für Normung, 6844-3. Nuklearmedizinische Betriebe; Strahlenschutzberechnungen (Installations for nuclear medicine; radiation protection calculations) 1989-2009.
13. D. J. Simpkin, "Shielding requirements for constant-potential diagnostic x-ray beams determined by a Monte Carlo calculation," Health Phys. 56, 151-164 (1989).
14. F. H. Fahey et al., "Positron emission tomography instrumentation design considerations for PET scanners," Radiol. Clin. North Am. 39, 919-929 (2001).
15. H. Everaert et al., "Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera," Eur. J. Nucl. Med. Mol. Imaging 30, 1615-1619 (2003).
16. G. Muehllehner, J. S. Karp, and S. Surti, "Design considerations for PET scanners," Q. J. Nucl. Med. 46, 16-23 (2002).
17. S. C. Jones et al, "The radiation dosimetry of 2 [F-18]fluoro-2-deoxy-D-glucose in man," J. Nucl. Med. 23, 613-617 (1982).
18. D. Swanson, H. Chilton, and J. Thrall, Pharmaceuticals in Medical Imaging (Macmillan Publishing Company, New York, 1990).
19. E. A. Wegner et al., "The impact of PET scanning on management of paediatric oncology patients," Eur. J. Nucl. Med. Mol. Imaging 32, 23-30 (2005).
20. A. Bixler, G. Springer, and R. Lovas, "Practical aspects of radiation safety for using fluorine-18," J. Nucl. Med. Technol. 27, 14-16 (1999).
21. T. F. Brown and N. J. Yasillo, "Radiation safety considerations for PET centers," J. Nucl. Med. Technol. 25, 98-102 (1997): quiz, 104-105.
22. C. Chiesa et al., "Radiation dose to technicians per nuclear medicine procedure: comparison between technetium-99m, gallium-67, and iodine-131 radiotracers and fluorine-18 fluorodeoxyglucose," Eur. J. Nucl. Med. 24, 1380-1389 (1997).
23. B. Cronin, P. K. Marsden, and M. J. O'Doherty, "Are restrictions to behaviour of patients required following fluorine-18 fluorodeoxyglucose positron emission tomographic studies?" Eur. J. Nucl. Med. 26, 121-128 (1999).
24. T. M. Lundberg, P. J. Gray, and M. L. Bartlett, "Measuring and minimizing the radiation dose to nuclear medicine technologists," J. Nucl. Med. Technol. 30, 25-30 (2002).
25. N. A. Benatar, B. F. Cronin, and M. J. O'Doherty, "Radiation dose rates from patients undergoing PET: Implications for technologists and waiting areas," Eur. J. Nucl. Med. 27, 583-589 (2000).
26. S. White et al., "Occupational exposure in nuclear medicine and PET," Clin Positron Imaging 3, 127-129 (2000).
27. B. W. Zeff and M. V. Yester, "Patient self-attenuation and technologist dose in positron emission tomography," Med. Phys. 32, 861-865 (2005).
28. W. Snyder et al., "MIRD Pamplet 5: Estimates of absrobed fractions for monenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom," J. Nucl. Med., Suppl. 10 Supplement 3, 44-45 (1969).
29. V. A. McCormick and J. A. Miklos, "Radiation dose to positron emission tomography technologists during quantitative versus qualitative studies," J. Nucl. Med. 34, 769-772 (1993).
30. N. L. McElroy, "Worker dose analysis based on real time dosimetry," Health Phys. 74, 608-609 (1998).
31. C. D. Greaves and W. B. Tindale, "Dose rate measurements from radiopharmaceuticals: Implications for nuclear medicine staff and for children with radioactive parents," Nucl. Med. Commun. 20, 179-187 (1999).
32. M. Griff, T. Berthold, and A. Buck, "Radiation exposure to sonographers from fluorine-18-FDG PET patients," J. Nucl. Med. Technol. 28, 186-187 (2000).
33. P. Lin and T. Beck, AAPM Report No. 39: Specification and Acceptance Testing of Computed Tomography Scanners (AAPM, New York, 1993), p. 95.